Dr Reddy’s Begins Process for Emergency Use Authorisation of Russian Covid-19 Vaccine Sputnik V

Posted on by

The pharma company will present the the safety profile of phase two study and interim data of phase three study of human adenoviral vector-based platform vaccine candidate in the review process.